EMAIL THIS PAGE TO A FRIEND

American journal of physiology. Heart and circulatory physiology

Aerobic exercise training increases plasma Klotho levels and reduces arterial stiffness in postmenopausal women.


PMID 24322608

Abstract

The Klotho gene is a suppressor of the aging phenomena, and the secretion as well as the circulation of Klotho proteins decrease with aging. Although habitual exercise has antiaging effects (e.g., a decrease in arterial stiffness), the relationship between Klotho and habitual exercise remains unclear. In the present study, we investigated the effect of habitual exercise on Klotho, with a particular focus on arterial stiffness. First, we examined the correlation between plasma Klotho concentration and arterial stiffness (carotid artery compliance and β-stiffness index) or aerobic exercise capacity [oxygen uptake at ventilatory threshold (VT)] in 69 healthy, postmenopausal women (50-76 years old) by conducting a cross-sectional study. Second, we tested the effects of aerobic exercise training on plasma Klotho concentrations and arterial stiffness. A total of 19 healthy, postmenopausal women (50-76 years old) were divided into two groups: control group and exercise group. The exercise group completed 12 wk of moderate aerobic exercise training. In the cross-sectional study, plasma Klotho concentrations positively correlated with carotid artery compliance and VT and negatively correlated with the β-stiffness index. In the interventional study, aerobic exercise training increased plasma Klotho concentrations and carotid artery compliance and decreased the β-stiffness index. Moreover, the changes in plasma Klotho concentration and arterial stiffness were found to be correlated. These results suggest a possible role for secreted Klotho in the exercise-induced modulation of arterial stiffness.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

G0251
β-Glucuronidase from bovine liver, Type B-1, ≥1,000,000 units/g solid
G0376
β-Glucuronidase from bovine liver, Type B-3, ≥2,000,000 units/g solid
G7396
β-Glucuronidase from Escherichia coli, Type IX-A, lyophilized powder, 1,000,000-5,000,000 units/g protein (30 min assay)
G7646
β-Glucuronidase from Escherichia coli, Type VII-A, lyophilized powder, 5,000,000-20,000,000 units/g protein, pH 6.8 (30 min assay)
G8162
β-Glucuronidase from Escherichia coli, aqueous glycerol solution, ≥5,000,000 units/g protein, pH 6.8 (biuret)
G8295
β-Glucuronidase from Escherichia coli, ≥10,000,000 units/g protein (30 min assay), recombinant, expressed in E. coli overproducing strain, lyophilized powder
G8420
β-Glucuronidase from Escherichia coli, ≥20,000 units/mg protein, recombinant, expressed in E. coli overproducing strain, lyophilized powder
G0799
β-Glucuronidase from Escherichia coli, >20,000,000 units/g protein, recombinant, expressed in E. coli, aqueous glycerol solution
G4259
β-Glucuronidase from Helix aspersa (garden snail), Type HA-4
G7017
β-Glucuronidase from Helix pomatia, Type HP-2, aqueous solution, ≥100,000 units/mL
G0876
β-Glucuronidase from Helix pomatia, Type H-2, aqueous solution, ≥85,000 units/mL
G7770
β-Glucuronidase from Helix pomatia, Type HP-2S, aqueous solution, ≥90,000 units/mL
G0751
β-Glucuronidase from Helix pomatia, Type H-1, partially purified powder, ≥300,000 units/g solid
G8885
β-Glucuronidase from Helix pomatia, Type H-3, aqueous solution, ≥90,000 units/mL
G1512
β-Glucuronidase from Helix pomatia, Type H-5, lyophilized powder, ≥400,000 units/g solid
G0762
β-Glucuronidase from Helix pomatia, Type H-3AF, aqueous solution, ≥60,000 units/mL
G8132
β-Glucuronidase from limpets (Patella vulgata), Type L-II, lyophilized powder, 1,000,000-3,000,000 units/g solid
G2174
β-Glucuronidase from limpets (Patella vulgata), aqueous solution, ≥85,000 units/mL